ProKidney (PROK) Institutional Ownership → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free PROK Stock Alerts $2.53 -0.19 (-6.99%) (As of 04/23/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for ProKidney (NASDAQ:PROK)CurrentInstitutional OwnershipPercentage51.59%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$3.10MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$8.03M Get PROK Insider Trade Alerts Want to know when executives and insiders are buying or selling ProKidney stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PROK Institutional Buying and Selling by Quarter Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry ProKidney Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/7/2024Jump Financial LLC21,677$39K0.0%-54.0%0.009% 1/31/2024Federated Hermes Inc.113,286$202K0.0%+10,984.7%0.048% 1/12/2024SG Americas Securities LLC46,829$83K0.0%+174.2%0.020% 11/7/2023New York State Common Retirement Fund17,274$79K0.0%-30.1%0.007% 11/7/2023Jump Financial LLC47,100$216K0.0%N/A0.020% 10/27/2023Social Capital Group LLC11,573,000$53.00M89.0%-12.8%4.922% 10/24/2023Bank of New York Mellon Corp127,956$586K0.0%-21.9%0.054% 10/13/2023SG Americas Securities LLC17,080$78K0.0%N/A0.007% 8/10/2023Letko Brosseau & Associates Inc.15,900$178K0.0%N/A0.007% 8/10/2023Metropolitan Life Insurance Co NY3,429$38K0.0%N/A0.001% 8/4/2023American International Group Inc.29,698$332K0.0%N/A0.013% 8/3/2023Bank of New York Mellon Corp163,811$1.83M0.0%N/A0.070% 7/31/2023Strs Ohio12,800$143K0.0%N/A0.005% 7/19/2023 Salem Investment Counselors Inc.3,000$34K0.0%+547.9%0.001% 2/13/2023Social Capital Group LLC13,273,000$91.05M77.7%N/A51.767% 2/8/2023Swiss National Bank74,301$510K0.0%N/A0.290% 1/24/2023Brown University1,000,000$6.86M2.9%N/A3.900% 11/15/2022Bleichroeder LP2,000,000$18.02M3.8%N/A7.800% 11/14/2022Verition Fund Management LLC14,603$132K0.0%N/A0.057% 11/14/2022Moore Capital Management LP26,500$239K0.0%N/A0.103% (Data available from 1/1/2016 forward) PROK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PROK shares? During the previous two years, 16 institutional investors and hedge funds held shares of ProKidney. The most heavily invested institutionals were Social Capital Group LLC ($53.00M), Bleichroeder LP ($18.02M), Brown University ($6.86M), Bank of New York Mellon Corp ($586K), Swiss National Bank ($510K), American International Group Inc. ($332K), and Moore Capital Management LP ($239K).Learn more on PROK's institutional investors. What percentage of ProKidney stock is owned by institutional investors? 51.59% of ProKidney stock is owned by institutional investors. Learn more on PROK's institutional investor holdings. Which institutional investors have been buying ProKidney stock? Of the 15 institutional investors that purchased ProKidney stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Social Capital Group LLC ($13.27M), Bleichroeder LP ($2M), Brown University ($1M), Bank of New York Mellon Corp ($163.81K), Federated Hermes Inc. ($112.26K), Swiss National Bank ($74.30K), and Jump Financial LLC ($47.10K). How much institutional buying is happening at ProKidney? Institutional investors have bought a total of 16,822,772 shares in the last 24 months. This purchase volume represents approximately $119.91M in transactions. Which ProKidney major shareholders have been selling company stock? The following institutional investors have sold ProKidney stock in the last 24 months: Social Capital Group LLC ($1.70M), Bank of New York Mellon Corp ($35.86K), Jump Financial LLC ($25.42K), and New York State Common Retirement Fund ($7.43K). How much institutional selling is happening at ProKidney? Institutional investors have sold a total of 1,768,704 shares in the last 24 months. This volume of shares sold represents approximately $8.03M in transactions. Related Companies: PRME Major Shareholders HLVX Major Shareholders ALLO Major Shareholders NVAX Major Shareholders MESO Major Shareholders FATE Major Shareholders EXAI Major Shareholders ALEC Major Shareholders CGEM Major Shareholders TSHA Major Shareholders This page (NASDAQ:PROK) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm PressThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProKidney Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
